Drugs / Selenium Supplement
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04662242 | Dec 2020 → Oct 2022 | infectious disease with sepsis | Chang Gung Memorial Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Selenium Supplement | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04662242 ↗ |
| Route | Intravenous | “iv infusion” NCT04662242 ↗ |